PIOLAX (5988) FY2026 Q3 Earnings Report

Quick View

Executive Summary

For the cumulative Q3 period of the fiscal year ending March 2026, the Company reported lower revenue and earnings, with earnings deteriorating more sharply than revenue. Revenue was ¥460.6B (¥479.5B in the same period of the previous year, YoY -4.0%), Operating Income was ¥12.1B (¥21.9B, YoY -44.7%), Ordinary Income was ¥11.7B (¥29.6B, YoY -60.4%), and Net Income attributable to owners of the parent was ¥6.5B (¥19.1B, YoY -65.5%). In addition to lower revenue from the core Automotive-related businesses and other operations, the increase in the cost-of-sales ratio and the SG&A ratio caused the Operating Income margin to decline to 2.6%. Increased interest payments, foreign exchange losses, and extraordinary losses further pressured lower-line earnings.

Factors Affecting Performance

【Revenue】Revenue was ¥460.6B (down 4.0% year on year). By segment, Automotive-related businesses and other operations, which account for 91.4% of consolidated revenue, declined to ¥421.0B (¥421.0B in the previous year, rather than the year-on-year figure, down 4.3% year on year) and were the primary factor behind the revenue decrease, while Medical Devices was ¥39.5B (down 0.5%), remaining almost flat. Both segments were on a declining revenue trend, indicating weakness in company-wide demand and capacity utilization.

【Profit and Loss】The gross profit margin declined from 23.2% in the same period of the previous year to 22.0%, indicating weaker cost absorption. SG&A expenses remained elevated at ¥89.4B, up 0.3% year on year. Together with the revenue decline, this caused operating leverage to work negatively, leaving Operating Income at ¥12.1B (down 44.7%). In non-operating items, interest payments surged from ¥0.08B to ¥1.64B, while a foreign exchange loss of ¥1.4B also contributed to reducing Ordinary Income to ¥11.7B (down 60.4%). In addition, extraordinary losses of ¥2.7B were recorded, reducing Net Income to ¥6.5B (down 65.5%). In conclusion, the Company reported lower revenue and earnings, with the key characteristic being that the downside earnings elasticity significantly exceeded the decline in revenue.

Segment Analysis

Automotive-related businesses and other operations recorded revenue of ¥421.0B (down 4.3% year on year) and segment profit of ¥18.1B (down 33.1%), with the profit margin declining by 184bp from 6.1% to 4.3%, making this the primary cause of the deterioration in company-wide earnings. Medical Devices recorded revenue of ¥39.5B (down 0.5%) and segment profit of ¥2.6B (down 21.7%), with the profit margin declining by 176bp from 8.2% to 6.5%. Although Medical Devices has a higher profit margin than Automotive-related businesses and other operations, its scale is small, accounting for 8.6% of revenue; therefore, its ability to support overall profitability through business mix is limited. While total segment profit was ¥20.6B (down 31.9%), company-wide expenses increased to ¥8.6B (up 2.4%), and the absorption of headquarters expenses also pressured consolidated Operating Income.

Key Financial Indicators

【Profitability】The Operating Income margin declined significantly to 2.6% (4.6% in the same period of the previous year), while the Net Income margin declined to 1.4% (3.9%). ROE was 1.4% on an annualized basis, and ROIC was only 1.8% on an annualized basis. Under DuPont decomposition, the decline in the Net Income margin was the primary cause of weak ROE, while the total asset turnover ratio of 0.60x and financial leverage of 1.57x remained largely unchanged. 【Cash Quality】Annualized DSO was 76 days and CCC was 138 days, indicating a buildup of working capital. Given the EBIT margin of 2.6%, the Company’s capacity to absorb this through internally generated funds is limited. 【Investment Efficiency】Construction in progress of ¥72.3B accounted for 19.3% of property, plant and equipment of ¥375.2B. While capital investment continues to accumulate, monetizing invested capital remains a challenge at an ROIC level of 1.8%. 【Financial Soundness】The Equity Ratio was 63.7%, the current ratio was 160.0%, and Debt/Capital was 28.6%, indicating a robust financial foundation. However, short-term borrowings of ¥260.0B account for all interest-bearing debt, and the coverage ratio based on cash and deposits of ¥263.3B remains only 1.01x.

Cash Flow Analysis

Although Operating, Investing, and Financing Cash Flow are not evaluated based on disclosures in the statement of cash flows, changes in the balance sheet provide some insight into fund flows. Cash and deposits have not changed significantly from ¥263.3B in the same period of the previous year to ¥34.9B; rather, short-term borrowings of ¥260.0B account for all interest-bearing debt, creating a structure in which nearly all borrowings are matched by cash and deposits. Customer receivables, comprising accounts receivable of ¥127.8B and electronically recorded monetary claims of ¥18.9B, reached ¥146.8B. Annualized DSO of 76 days and CCC of 138 days indicate that working capital is impairing capital efficiency. Inventories were ¥57.4B, accounting for 5.6% of total assets. Considering the allocation among finished goods, work in process, and raw materials, reducing inventories and receivables will be key to improving future cash-generation capacity.

Earnings Quality

Operating Income, representing recurring business earnings, declined significantly to ¥12.1B, down 44.7% year on year. In addition, non-operating expenses—including interest payments of ¥1.6B, foreign exchange losses of ¥1.4B, and commission fees of ¥2.0B, which are relatively non-recurring items—further reduced Ordinary Income. Extraordinary losses of ¥2.7B constituted a temporary factor that reduced Profit Before Tax to ¥9.0B. After deducting income taxes and other taxes of ¥2.4B from Profit Before Tax of ¥9.0B, Net Income was ¥6.6B, corresponding to an effective tax burden ratio of 26.7%. This reflects the consistent transmission of declining profitability from the operating stage through to final earnings. In addition to temporary expense recognition, the primary factor was the structural decline in the profitability of the core business. Comprehensive Income was negative ¥3.8B, mainly due to negative foreign currency translation adjustments of ¥13.1B. The gap versus Net Income of ¥6.6B indicates the significant impact of foreign exchange valuation of overseas assets and liabilities on shareholders’ equity.

Earnings Forecast and Guidance

The full-year forecast is revenue of ¥612.0B (down 3.4% year on year), Operating Income of ¥16.0B (down 32.8%), Ordinary Income of ¥15.0B (down 55.9%), and Net Income of ¥7.0B. While the cumulative Q3 progress rates of 75.3% for revenue and 75.8% for Operating Income are generally at standard levels, Net Income was ¥6.5B, reaching a progress rate of 92.6%; accordingly, the forecast incorporates a limited contribution from Net Income in Q4. Revenue of ¥151.4B and Operating Income of ¥3.9B are required in Q4, and no improvement in profitability above the cumulative Operating Income margin of 2.6% is assumed.

Shareholder Returns

The Q2 dividend was ¥39.00 per share, and the full-year forecast dividend is ¥92.00. The dividend-only Payout Ratio against Net Income of ¥6.5B (attributable to owners of the parent), calculated in comparison with forecast EPS of ¥27.44, is approximately 335%, representing a return plan significantly exceeding the current-period earnings level. Retained earnings of ¥753.0B provide substantial capacity as a source of dividends; however, the sustainability of capital allocation—including the balance with earnings recovery and reliance on borrowings—is a point of consideration given the high dividend level during a period of declining profitability, with an Operating Income margin of 2.6% and ROIC of 1.8%. In addition, treasury shares increased by ¥236.9B year on year to ¥290.96B, and capital policy involving share repurchases, separate from dividends, is also having a significant impact on net asset levels.

Risk Factors

1. Risk of deteriorating profitability in the core business: Automotive-related businesses and other operations account for 91.4% of consolidated revenue, and the segment profit margin declined from 6.1% to 4.3%. Recovery in the capacity utilization and pricing power of this business is the largest variable for company-wide performance.

2. Risk of concentration in short-term funding: Short-term borrowings of ¥260.0B account for all interest-bearing debt, and the coverage ratio based on cash and deposits of ¥263.3B remains only 1.01x. Interest payments have increased sharply year on year, and the interest burden coefficient of 0.744 represents a level at which approximately 26% of EBIT is reduced by financial expenses and other items.

3. Risk of working capital buildup: Annualized DSO of 76 days and CCC of 138 days both exceed cautionary levels. The buildup of working capital during a low-profitability period, with an Operating Income margin of 2.6%, will pressure capital efficiency and the ability to convert earnings into cash.

Industry Benchmark (Reference, Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

The Company’s profitability is significantly below the industry median, with both its Operating Income margin and Net Income margin positioned in the lower tier of the industry.

Growth and Capital Efficiency

While the industry median indicates positive growth, the Company recorded a revenue decline and is therefore positioned behind its industry peers in terms of growth.

※Source: Compiled by the Company

Key Takeaways from the Financial Results

1. The fact that Operating Income declined by 44.7% and Net Income by 65.5% against a 4.0% revenue decline indicates that downside earnings elasticity significantly exceeds revenue fluctuations. This warrants attention from both fixed-cost structure and cost-absorption perspectives.

2. The combination of short-term borrowings of ¥260.0B accounting for all interest-bearing debt, an interest burden coefficient of 0.744, and annualized CCC of 138 days requires ongoing monitoring as a structural issue in terms of financial efficiency.

3. Against a Net Income progress rate of 92.6% under the full-year forecast, the Payout Ratio is calculated at approximately 335% (based on the full-year forecast). The divergence between earnings levels and the return plan, together with the increase in treasury shares to ¥290.96B, is a key point identifiable from the financial results in assessing the overall capital allocation picture.

Theoretical Share Price (Reference Value)

Sensitivity: ¥2,009–¥2,120 for a ±1% change in the cost of equity, and ¥2,046–¥2,075 for a ±0.1 change in ω.

Notes:

• Net Income is significantly compressed relative to Operating Income due to tax burden, acquisition-related expenses, non-controlling interests, and other factors (Net Income ÷ Operating Income 44%). This value reflects that compression at face value; if the factors are temporary, underlying earnings power may be higher.
• Because forecast ROE is below the cost of equity, the theoretical value is below Book Value per Share.
• Net assets as of the quarter-end are used; there is a timing difference from the full-year forecast.
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model (Ohlson type, explicit 5-year fade) / Interest-rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; it is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting professionals as necessary.

---End of Report---